P40 immunohistochemistry is an excellent marker in primary lung squamous cell carcinoma

Khairunisa Ahmad Affandi, Nur Maya Sabrina Tizen, Muaatamarulain Mustangin, Reena Rahayu Md Zain

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Background: Lung cancer is the third most common cancer worldwide. With major advances in the molecular testing of lung cancers and the introduction of targeted therapies, the distinction between adenocarcinoma and squamous cell carcinoma as well as pathologic subtyping has become important. Recent studies showed that p40 is highly specific for squamous and basal cells and is superior to p63 for diagnosing lung squamous cell carcinoma. The aim of this study was to evaluate the use of p40 immunohistochemical stain in the diagnosis of non-small cell lung carcinoma and its potential to replace current p63 antibody as the best immunohistochemical squamous marker. Methods: Seventy formalin-fixed paraffin-embedded cases previously diagnosed as primary lung squamous cell carcinoma (n = 35) and lung adenocarcinoma (n = 35) from January 2008 to December 2016 were retrieved. The results of tumour cell immunoreactivity for p40 and p63 antibodies in lung squamous cell carcinoma and lung adenocarcinoma were compared. Results: P40 was expressed in 27 cases of lung squamous cell carcinoma (77.1%). All cases of lung adenocarcinoma (35/35, 100%) were negative for p40. p63 expression was positive in 30 cases of lung squamous cell carcinoma (85.7%) and 13 cases of lung adenocarcinoma (37.1%). Reactivity for both p40 and p63 in lung squamous cell carcinoma was strong and diffuse, whereas variable reactivity was observed in lung adenocarcinoma. Conclusions: P40 is an excellent marker for distinguishing lung squamous cell carcinoma from adenocarcinoma, and p40 expression is equivalent to p63 expression in lung squamous cell carcinoma.

Original languageEnglish
Pages (from-to)283-289
Number of pages7
JournalJournal of Pathology and Translational Medicine
Volume52
Issue number5
DOIs
Publication statusPublished - 1 Sep 2018

Fingerprint

Squamous Cell Carcinoma
Immunohistochemistry
Lung
Lung Neoplasms
Adenocarcinoma
adjuvant P40
Antibodies
Non-Small Cell Lung Carcinoma
Paraffin
Formaldehyde
Neoplasms
Coloring Agents
Epithelial Cells
Adenocarcinoma of lung

Keywords

  • Immunohistochemistry
  • Lung neoplasms
  • Non-small cell lung carcinoma
  • p40
  • p63

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Histology

Cite this

P40 immunohistochemistry is an excellent marker in primary lung squamous cell carcinoma. / Affandi, Khairunisa Ahmad; Tizen, Nur Maya Sabrina; Mustangin, Muaatamarulain; Md Zain, Reena Rahayu.

In: Journal of Pathology and Translational Medicine, Vol. 52, No. 5, 01.09.2018, p. 283-289.

Research output: Contribution to journalArticle

Affandi, Khairunisa Ahmad ; Tizen, Nur Maya Sabrina ; Mustangin, Muaatamarulain ; Md Zain, Reena Rahayu. / P40 immunohistochemistry is an excellent marker in primary lung squamous cell carcinoma. In: Journal of Pathology and Translational Medicine. 2018 ; Vol. 52, No. 5. pp. 283-289.
@article{1083c04e5ee949438731128c463fc324,
title = "P40 immunohistochemistry is an excellent marker in primary lung squamous cell carcinoma",
abstract = "Background: Lung cancer is the third most common cancer worldwide. With major advances in the molecular testing of lung cancers and the introduction of targeted therapies, the distinction between adenocarcinoma and squamous cell carcinoma as well as pathologic subtyping has become important. Recent studies showed that p40 is highly specific for squamous and basal cells and is superior to p63 for diagnosing lung squamous cell carcinoma. The aim of this study was to evaluate the use of p40 immunohistochemical stain in the diagnosis of non-small cell lung carcinoma and its potential to replace current p63 antibody as the best immunohistochemical squamous marker. Methods: Seventy formalin-fixed paraffin-embedded cases previously diagnosed as primary lung squamous cell carcinoma (n = 35) and lung adenocarcinoma (n = 35) from January 2008 to December 2016 were retrieved. The results of tumour cell immunoreactivity for p40 and p63 antibodies in lung squamous cell carcinoma and lung adenocarcinoma were compared. Results: P40 was expressed in 27 cases of lung squamous cell carcinoma (77.1{\%}). All cases of lung adenocarcinoma (35/35, 100{\%}) were negative for p40. p63 expression was positive in 30 cases of lung squamous cell carcinoma (85.7{\%}) and 13 cases of lung adenocarcinoma (37.1{\%}). Reactivity for both p40 and p63 in lung squamous cell carcinoma was strong and diffuse, whereas variable reactivity was observed in lung adenocarcinoma. Conclusions: P40 is an excellent marker for distinguishing lung squamous cell carcinoma from adenocarcinoma, and p40 expression is equivalent to p63 expression in lung squamous cell carcinoma.",
keywords = "Immunohistochemistry, Lung neoplasms, Non-small cell lung carcinoma, p40, p63",
author = "Affandi, {Khairunisa Ahmad} and Tizen, {Nur Maya Sabrina} and Muaatamarulain Mustangin and {Md Zain}, {Reena Rahayu}",
year = "2018",
month = "9",
day = "1",
doi = "10.4132/jptm.2018.08.14",
language = "English",
volume = "52",
pages = "283--289",
journal = "Journal of Pathology and Translational Medicine",
issn = "2383-7837",
publisher = "Korean Society of Pathologists",
number = "5",

}

TY - JOUR

T1 - P40 immunohistochemistry is an excellent marker in primary lung squamous cell carcinoma

AU - Affandi, Khairunisa Ahmad

AU - Tizen, Nur Maya Sabrina

AU - Mustangin, Muaatamarulain

AU - Md Zain, Reena Rahayu

PY - 2018/9/1

Y1 - 2018/9/1

N2 - Background: Lung cancer is the third most common cancer worldwide. With major advances in the molecular testing of lung cancers and the introduction of targeted therapies, the distinction between adenocarcinoma and squamous cell carcinoma as well as pathologic subtyping has become important. Recent studies showed that p40 is highly specific for squamous and basal cells and is superior to p63 for diagnosing lung squamous cell carcinoma. The aim of this study was to evaluate the use of p40 immunohistochemical stain in the diagnosis of non-small cell lung carcinoma and its potential to replace current p63 antibody as the best immunohistochemical squamous marker. Methods: Seventy formalin-fixed paraffin-embedded cases previously diagnosed as primary lung squamous cell carcinoma (n = 35) and lung adenocarcinoma (n = 35) from January 2008 to December 2016 were retrieved. The results of tumour cell immunoreactivity for p40 and p63 antibodies in lung squamous cell carcinoma and lung adenocarcinoma were compared. Results: P40 was expressed in 27 cases of lung squamous cell carcinoma (77.1%). All cases of lung adenocarcinoma (35/35, 100%) were negative for p40. p63 expression was positive in 30 cases of lung squamous cell carcinoma (85.7%) and 13 cases of lung adenocarcinoma (37.1%). Reactivity for both p40 and p63 in lung squamous cell carcinoma was strong and diffuse, whereas variable reactivity was observed in lung adenocarcinoma. Conclusions: P40 is an excellent marker for distinguishing lung squamous cell carcinoma from adenocarcinoma, and p40 expression is equivalent to p63 expression in lung squamous cell carcinoma.

AB - Background: Lung cancer is the third most common cancer worldwide. With major advances in the molecular testing of lung cancers and the introduction of targeted therapies, the distinction between adenocarcinoma and squamous cell carcinoma as well as pathologic subtyping has become important. Recent studies showed that p40 is highly specific for squamous and basal cells and is superior to p63 for diagnosing lung squamous cell carcinoma. The aim of this study was to evaluate the use of p40 immunohistochemical stain in the diagnosis of non-small cell lung carcinoma and its potential to replace current p63 antibody as the best immunohistochemical squamous marker. Methods: Seventy formalin-fixed paraffin-embedded cases previously diagnosed as primary lung squamous cell carcinoma (n = 35) and lung adenocarcinoma (n = 35) from January 2008 to December 2016 were retrieved. The results of tumour cell immunoreactivity for p40 and p63 antibodies in lung squamous cell carcinoma and lung adenocarcinoma were compared. Results: P40 was expressed in 27 cases of lung squamous cell carcinoma (77.1%). All cases of lung adenocarcinoma (35/35, 100%) were negative for p40. p63 expression was positive in 30 cases of lung squamous cell carcinoma (85.7%) and 13 cases of lung adenocarcinoma (37.1%). Reactivity for both p40 and p63 in lung squamous cell carcinoma was strong and diffuse, whereas variable reactivity was observed in lung adenocarcinoma. Conclusions: P40 is an excellent marker for distinguishing lung squamous cell carcinoma from adenocarcinoma, and p40 expression is equivalent to p63 expression in lung squamous cell carcinoma.

KW - Immunohistochemistry

KW - Lung neoplasms

KW - Non-small cell lung carcinoma

KW - p40

KW - p63

UR - http://www.scopus.com/inward/record.url?scp=85055658018&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85055658018&partnerID=8YFLogxK

U2 - 10.4132/jptm.2018.08.14

DO - 10.4132/jptm.2018.08.14

M3 - Article

VL - 52

SP - 283

EP - 289

JO - Journal of Pathology and Translational Medicine

JF - Journal of Pathology and Translational Medicine

SN - 2383-7837

IS - 5

ER -